Fentanyl and Metabolite, Urine, Quantitative
0092570
Ordering Recommendation
Preferred test to follow-up presumptive results. For general screening, Fentanyl, Urine Screen with Reflex to Quantitation (2012284) is preferred.
Mnemonic
CDCO FENU
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Tue, Thu, Sat
Reported
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
- Patient Preparation
- Collect
- Random urine.
- Specimen Preparation
- Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 0.5 mL)
- Storage/Transport Temperature
- Room temperature.
- Unacceptable Conditions
- Specimens exposed to repeated freeze/thaw cycles.
- Remarks
- Stability
- Ambient: 1 month; Refrigerated: 1 month; Frozen: 9 months
Reference Interval
| Drugs Covered | Cutoff Concentrations |
| Fentanyl | 1.0 ng/mL |
| Norfentanyl | 1.0 ng/mL |
Interpretive Data
Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Positive cutoff: 1.0 ng/mL
For medical purposes only; not valid for forensic use.
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
Positive cutoff: 1.0 ng/mL
For medical purposes only; not valid for forensic use.
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Note
Hotline History
View Hotline History
CPT Code(s)
80354 (Alt code: G0480)
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2005886 | Fentanyl, Urn, Quant | 3637-6 |
| 2005887 | Norfentanyl, Urn, Quant | 11075-9 |
Aliases
- Actiq
- Duragesic
- Durogesic
- fentanyl and norfentanyl urine concentrations
- Fentanyl, Quantitative, with medMATCH, Urine
- Fentora
- Innovar
- Instanyl
- Ionsys
- Onsolis
- Sublimaze